Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
07/2003
07/01/2003US6586186 Nucleotide sequences for use in the detection of gene rearrangements
07/01/2003US6586185 Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances
07/01/2003US6586184 Rearranging target nucleotide sequences; obtain cells, transfor with nucleotide sequences, detecting nucleotide sequences adjustment in prokaryotic cell
07/01/2003US6586183 Nucleotide sequences coding preferential protein; for use in the treatment of asthma, obesity, hypertension, arrhythmia, migraine, chronic obstructive pulmonary disease, anaphylaxis, myasthenia gravis and premature labor
07/01/2003US6586182 Selecting amino acid sequence variations based on computer modeling; polynucleotides comprising subsequences of nucleic acids encoding the amino acid variations; reassembling into nucleotide sequences encoding mutagenized polypeptides
07/01/2003US6586181 Method for detecting allelic imbalance
07/01/2003US6586180 Directed antisense libraries
07/01/2003US6586179 Human Eag2
07/01/2003US6586177 Methods for disease detection
07/01/2003US6586176 Gel microdrops in genetic analysis
07/01/2003US6586175 Genotyping the human UDP-glucuronosyltransferase 2B7 (UGT2B7) gene
07/01/2003US6586174 Detecting CD8+ by contacting with culture of cells that contain recombinant DNA expression vector in which a reporter gene is associated with promoter sequence; measuring inhibition of reporter gene; can use in drugs for AIDS
07/01/2003US6585968 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
07/01/2003US6585954 Method for searching steroid sulfatase inhibitors
07/01/2003US6585939 Microstructures for use in biological assays and reactions
07/01/2003US6585937 Electrochemical analysis system
07/01/2003CA2221769C Method for quantitatively determining an antibody having the ability to inhibit the activity of a reverse transcriptase
07/01/2003CA2122338C Novel human cdc25 genes, encoded products and uses therefor
07/01/2003CA2066387C Viral products
07/01/2003CA2056983C Process for nucleic acid hybridization and amplification
07/01/2003CA2046917C Polypeptides having thyrotropin-receptor activity, nucleic acid sequences coding for such receptors and polypeptides, and applications of these polypeptides
06/2003
06/28/2003WO2003057905A1 Method of colorimetry and reagent for use therein
06/27/2003CA2415012A1 Method for determining biospecies contained in test specimen and kit used for the same
06/26/2003WO2003052425A2 Elisa kit for cyp 2c9 metabolic phenotypes
06/26/2003WO2003052421A1 Electro-chemical analysis device with integrated thermal sensor
06/26/2003WO2003052420A2 Device and bioanalytical method utilizing asymmetric biofunction alized membrane
06/26/2003WO2003052408A1 Method of screening drug
06/26/2003WO2003052380A2 Recruitment of mst1 or mst2 protein kinase to induce apoptosis in eukaryotic cells
06/26/2003WO2003052376A2 Method and apparatus for dna collection
06/26/2003WO2003052375A2 Device and methods for monitoring the status of at least one cell
06/26/2003WO2003052374A2 Methods for identifying racemases
06/26/2003WO2003052144A1 Diagnostic assays for bcwa
06/26/2003WO2003052143A2 New primers for the detection and identification of bacterial indicator groups and virulence factors
06/26/2003WO2003052142A2 Analysis and detection of multiple target sequences using circular probes
06/26/2003WO2003052141A2 High troughput analysis and detection of multiple target sequences using circular probes
06/26/2003WO2003052140A2 High throughput analysis and detection of multiple target sequences
06/26/2003WO2003052139A1 Discrimination method of hybridization between probes and nucleotides in sample on the bio chip using enzyme reaction
06/26/2003WO2003052138A2 Methods of detecting modification of genetic material
06/26/2003WO2003052137A2 Evanescence-based multiplex sequencing method
06/26/2003WO2003052136A2 Sequencing on perforated membranes
06/26/2003WO2003052135A2 Method and nucleic acids for the analysis of a lung cell proliferative disorder
06/26/2003WO2003052134A2 Oligonucleotides comprising intercalator pseudonucleotide(s) for detection of nucleic acids and mutants hereof
06/26/2003WO2003052133A2 Oligonucleotide analogues comprising intercalator pseudonucleotides
06/26/2003WO2003052132A2 Linear and hairpin oligonucleotide analogues comprising intercalator pseudonucleotides
06/26/2003WO2003052130A2 A method for determining the biological activity of defibrotide
06/26/2003WO2003052129A1 Method for assessing the risk of cardiovascular disease
06/26/2003WO2003052128A1 A method and a kit for determination of a microbial count
06/26/2003WO2003052127A1 Method of detecting and estimating water contamination
06/26/2003WO2003052126A1 Method of detection and enumeration of bacteria
06/26/2003WO2003052125A1 Non-or minimally invasive monitoring methods
06/26/2003WO2003052124A2 Screening method for agents useful in treating diabetes
06/26/2003WO2003052123A1 Individualization of therapy with antihistamines
06/26/2003WO2003052121A2 Method of reducing angiogenesis
06/26/2003WO2003052116A2 Methods for detection of a target nucleic acid using multi-subunit probes
06/26/2003WO2003052115A2 Post-synthesis labeling of nucleic acids and uses thereof
06/26/2003WO2003052106A1 Method of screening compounds
06/26/2003WO2003052101A1 Sample tracking using molecular barcodes
06/26/2003WO2003052099A2 Methods of parallel gene cloning and analysis
06/26/2003WO2003052097A1 Potentiometric dna microarray, process for producing the same and method of analyzing nucleic acid
06/26/2003WO2003052096A1 Mtehod of analyzing gene expression
06/26/2003WO2003052089A1 Disruption of the glutathione s-transferase-omega-1 gene
06/26/2003WO2003052078A2 Insect g protein-coupled receptor genes and uses thereof
06/26/2003WO2003052076A2 Identification of essential genes of cryptococcus neoformans and methods of use
06/26/2003WO2003052074A2 Nucleic acid diagnostic reagents and methods for detecting nucleic acids, polynucleotides and oligonucleotides
06/26/2003WO2003052069A2 FLJ1115 AS MODIFIER OF THE Apaf-1 PATHWAY AND METHODS OF USE
06/26/2003WO2003052066A2 Klcs as modifiers of the p53 pathway and methods of use
06/26/2003WO2003052056A2 Egviii endoglucanase and nucleic acids encoding the same
06/26/2003WO2003052050A2 P450 enzymes, nucleic acids encoding them and methods of making and using them
06/26/2003WO2003052048A2 Nucleic acid-associated proteins
06/26/2003WO2003051923A2 Novel g-protein coupled receptors and dna sequences thereof
06/26/2003WO2003051917A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
06/26/2003WO2003051915A1 A modulation protein with apoptosis coronary heart disease
06/26/2003WO2003051905A2 Taojiks as modifiers of the beta-catenin pathway and methods of use
06/26/2003WO2003051901A2 Pseudonucleotide comprising an intercalator
06/26/2003WO2003051506A1 Membrane
06/26/2003WO2003051419A1 Skin/hair equivalent with reconstructed papillae
06/26/2003WO2003051388A2 Pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
06/26/2003WO2003051302A2 Methods and compositions for treatment of central nervous system disorders
06/26/2003WO2003051182A2 Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia
06/26/2003WO2003051180A2 METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 252, 304, 19870, 14717, 9941, 19310 and 17832
06/26/2003WO2003051174A2 Single nucleotide polymorphisms and mutations on alpha-2-macroglobulin
06/26/2003WO2003035678A3 Sperm factor sequences
06/26/2003WO2003023389A3 Solid electrochemical sensor
06/26/2003WO2003014153A8 Cellular virus receptors and methods of use.
06/26/2003WO2003000721A3 Mycobacterial antigens expressed under low oxygen tension
06/26/2003WO2002102855A3 In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
06/26/2003WO2002101351A3 Method for detecting transcription factor-protein interactions
06/26/2003WO2002095416A3 Method for identifying micro-organisms using mass spectrometry
06/26/2003WO2002093128A3 Identifying insulin response modulators and therapeutic uses thereof
06/26/2003WO2002087606A3 Modulators of the hypocretin system and methods of screening therefor
06/26/2003WO2002081678A3 Method of separating alleles
06/26/2003WO2002078610A3 Pak2: modulators of lymphocyte activation
06/26/2003WO2002070696A3 Cd109 nucleic acid molecules polypeptides and methods of use
06/26/2003WO2002064781A3 Regulation of amyloid precursor protein expression by modification of abc transporter expression or activity
06/26/2003WO2002064766A3 Bax-responsive genes for drug target identification in yeast and fungi
06/26/2003WO2002061129A3 Oligonucleotide identifiers
06/26/2003WO2002060340A3 Method for identifying maxi-k channel blockers
06/26/2003WO2002059354A3 Polynucleotides for use as tags and tag complements, manufacture and use thereof
06/26/2003WO2002057410A3 Genetic typing of human genes and related materials and methods
06/26/2003WO2002048390A3 Methods and kits for detecting protein kinases
1 ... 2094 2095 2096 2097 2098 2099 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 ... 3003